
Acorda Therapeutics ACOR
Acorda Therapeutics ROCE | ACOR
ROCE Jährlich Acorda Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 167.74 | -37.75 | -52.3 | -15.76 | -43.69 | 3.32 | -22.09 | -3.01 | 3.31 | 3.77 | 5.95 | 5.49 | 12.0 | -5.57 | -59.17 | -35.45 | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 167.74 | -59.17 | -4.58 |
ROCE Vierteljährlich Acorda Therapeutics
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -13.97 | -31.12 | -42.68 | -50.42 | -35.51 | -49.5 | -51.15 | -49.27 | -36.18 | -31.06 | -20.36 | -14.13 | -0.18 | -92.36 | -101.77 | -106.14 | -104.13 | -99.41 | 2.51 | 6.88 | 14.54 | 14.22 | 9.89 | -2.1 | -2.19 | -3.01 | -4.78 | -7.68 | -5.42 | -0.96 | 0.88 | 2.74 | 5.25 | 9.24 | 6.96 | 6.71 | 6.94 | 9.6 | 7.78 | 4.95 | 4.19 | 8.41 | 7.95 | 9.83 | 10.47 | 21.52 | 17.87 | 15.95 | 11.91 | 21.22 | 5.52 | 0.28 | 9.32 | -4.65 |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 21.52 | -106.14 | -13.09 |
ROCE anderer Aktien in der Pharmaeinzelhändler
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Kaleido Biosciences
KLDO
|
-826.5 | - | -3.69 % | $ 12.4 M | ||
|
VBI Vaccines
VBIV
|
-712.54 | - | -50.87 % | $ 1.09 M | ||
|
CTI BioPharma Corp.
CTIC
|
453.99 | - | - | $ 1.2 B | ||
|
Decibel Therapeutics
DBTX
|
-63.37 | - | - | $ 123 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-4.03 | $ 26.35 | -3.02 % | $ 3.35 B | ||
|
IVERIC bio
ISEE
|
-35.52 | - | - | $ 5.51 B | ||
|
ObsEva SA
OBSV
|
-182.2 | - | -15.52 % | $ 10.5 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
-49.57 | $ 41.53 | -4.86 % | $ 5.88 B | ||
|
Monopar Therapeutics
MNPR
|
-12.11 | $ 69.02 | -1.81 % | $ 512 M | ||
|
Poseida Therapeutics
PSTX
|
-124.88 | - | - | $ 857 M | ||
|
Y-mAbs Therapeutics
YMAB
|
-33.91 | - | - | $ 382 M | ||
|
Satsuma Pharmaceuticals
STSA
|
-151.52 | - | -0.9 % | $ 36.5 M | ||
|
Anavex Life Sciences Corp.
AVXL
|
-54.19 | $ 0.59 | -11.3 % | $ 50.3 M | ||
|
SpringWorks Therapeutics
SWTX
|
-57.08 | - | - | $ 3.48 B | ||
|
Axon Enterprise
AXON
|
-1.91 | $ 291.02 | -5.2 % | $ 22.7 B | ||
|
Infinity Pharmaceuticals
INFI
|
235.39 | - | -46.98 % | $ 3.57 M | ||
|
Ayala Pharmaceuticals
AYLA
|
3412.47 | - | - | $ 7.46 M | ||
|
Evelo Biosciences
EVLO
|
2172.8 | - | -14.46 % | $ 27.9 M | ||
|
Morphic Holding
MORF
|
-25.64 | - | - | $ 2.42 B | ||
|
Genocea Biosciences
GNCA
|
-139.72 | - | -15.0 % | $ 3.04 M | ||
|
Biogen
BIIB
|
14.56 | $ 249.55 | 0.98 % | $ 36.6 B | ||
|
Bristol-Myers Squibb Company
BMY
|
5.3 | $ 58.74 | 0.69 % | $ 119 B | ||
|
Eiger BioPharmaceuticals
EIGR
|
496.51 | - | -9.21 % | $ 2.55 M | ||
|
IGM Biosciences
IGMS
|
-432.99 | - | - | $ 76.9 M | ||
|
Merrimack Pharmaceuticals
MACK
|
-10.87 | - | - | $ 216 M | ||
|
Rubius Therapeutics
RUBY
|
-1179.34 | - | -33.55 % | $ 7.81 M | ||
|
Mirati Therapeutics
MRTX
|
-76.22 | - | - | $ 3.3 B | ||
|
InVivo Therapeutics Holdings Corp.
NVIV
|
-67.64 | - | -37.48 % | $ 476 K | ||
|
Bellicum Pharmaceuticals
BLCM
|
-1339.01 | - | -9.72 % | $ 5.89 M | ||
|
Orchard Therapeutics plc
ORTX
|
-129.33 | - | 1.02 % | $ 90.8 M | ||
|
La Jolla Pharmaceutical Company
LJPC
|
-32.71 | - | - | $ 154 M | ||
|
Oyster Point Pharma
OYST
|
-97.1 | - | - | $ 300 M | ||
|
Intercept Pharmaceuticals
ICPT
|
-5.84 | - | - | $ 643 M | ||
|
Chinook Therapeutics
KDNY
|
-35.37 | - | - | $ 2.6 B | ||
|
Syros Pharmaceuticals
SYRS
|
-774.14 | - | -8.44 % | $ 3.4 M | ||
|
NanoViricides
NNVC
|
-95.56 | $ 1.15 | -2.54 % | $ 23.2 M | ||
|
GT Biopharma
GTBP
|
-214.65 | $ 2.93 | -7.86 % | $ 16.2 M | ||
|
Zymeworks
ZYME
|
-86.57 | $ 26.41 | -1.68 % | $ 1.36 B | ||
|
Aldeyra Therapeutics
ALDX
|
-79.69 | $ 0.84 | 16.41 % | $ 50.4 M | ||
|
Citius Pharmaceuticals
CTXR
|
-57.03 | $ 0.51 | 1.61 % | $ 5.64 M | ||
|
Cytokinetics, Incorporated
CYTK
|
-50.1 | $ 50.7 | -1.48 % | $ 6.09 M | ||
|
DBV Technologies S.A.
DBVT
|
-83.7 | $ 9.03 | -4.14 % | $ 1.26 B | ||
|
Precision BioSciences
DTIL
|
-35.84 | $ 7.37 | 6.66 % | $ 94.5 M | ||
|
Exelixis
EXEL
|
35.76 | $ 64.59 | -1.88 % | $ 17.5 B | ||
|
Fennec Pharmaceuticals
FENC
|
-10.46 | $ 13.09 | -2.68 % | $ 374 M | ||
|
Cardiff Oncology
CRDF
|
-107.63 | $ 0.85 | -4.67 % | $ 56.8 M | ||
|
BioNTech SE
BNTX
|
-7.08 | $ 80.87 | -0.63 % | $ 19.5 B | ||
|
Alkermes plc
ALKS
|
13.07 | $ 44.89 | -2.79 % | $ 7.39 B | ||
|
ANI Pharmaceuticals
ANIP
|
9.56 | $ 68.6 | -0.77 % | $ 1.38 B | ||
|
AIM ImmunoTech
AIM
|
2638.91 | $ 0.11 | -7.75 % | $ 178 K |